JP Morgan Chase’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
JP Morgan Chase's UTHR Position: Q3 2026 in Review
JP Morgan Chase reduced its United Therapeutics (UTHR) stake by 28% in Q3 2026, selling an estimated $40.5M and leaving 197,107 shares worth $95.9M. The position accounts for 0.01% of the portfolio, ranked #1069.
JP Morgan Chase first reported a position in UTHR in Q2 2013 and has held it in 54 quarters since. The position peaked at $172M in Q1 2026. 848 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- JP Morgan Chase held 197,107 shares of United Therapeutics worth $95.9M as of Q3 2026.
- JP Morgan Chase sold 78,251 United Therapeutics shares in Q3 2026, an estimated $40.5M.
- United Therapeutics made up 0.01% of JP Morgan Chase's portfolio in Q3 2026, its #1069 holding.
- JP Morgan Chase first reported a position in United Therapeutics in Q2 2013 and has held it in 54 quarters since.
- JP Morgan Chase's United Therapeutics position peaked at $172M in Q1 2026.
- 848 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.